Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
100M
-
Shares change
-
-2.72M
-
Total reported value, excl. options
-
$144M
-
Value change
-
-$4.78M
-
Put/Call ratio
-
0.61
-
Number of buys
-
30
-
Number of sells
-
-44
-
Price
-
$1.44
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q3 2020
107 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2020.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 100M shares
of 363M outstanding shares and own 27.58% of the company stock.
Largest 10 shareholders include Artal Group S.A. (60.2M shares), FMR LLC (9.29M shares), Ulys, L.L.C. (4.32M shares), VANGUARD GROUP INC (2.85M shares), NEA Management Company, LLC (2.38M shares), ACADIAN ASSET MANAGEMENT LLC (1.85M shares), LAZARD ASSET MANAGEMENT LLC (1.75M shares), FEDERATED HERMES, INC. (1.71M shares), RENAISSANCE TECHNOLOGIES LLC (1.63M shares), and MORGAN STANLEY (1.39M shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.